MD Banner University Medical Center /Arizona University
Welcome,         Profile    Billing    Logout  
 0 Trials 
2 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Bime, Christian
REPAVID-22, NCT05254990 / 2021-006951-32: Reparixin add-on Therapy to Std Care to Limit Progression in Pts With COVID19 & Other Community Acquired Pneumonia

Recruiting
3
526
Europe, US, RoW
Reparixin, Repertaxin L-lysine salt, Placebo, Matched placebo
Dompé Farmaceutici S.p.A
Infectious Pneumonia, Severe COVID-19
09/24
10/24
ARREST, NCT04193878: ARrest RESpiraTory Failure From PNEUMONIA

Recruiting
3
600
US
Inhaled budesonide and formoterol, Pulmicort Respules (budesonide) and Perforomist (formoterol), Inhaled placebo, aerosolized 0.9% saline
Stanford University, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH)
Pneumonia, Hypoxemia, Acute Respiratory Failure, COVID-19 Pneumonia
07/25
08/25

Download Options